Investments
499Portfolio Exits
97About Morgenthaler Ventures
Morgenthaler is a leading U.S. venture-capital firm with offices in Menlo Park, California; Boston, Massachusetts; Princeton, New Jersey; Boulder, Colorado and Cleveland, Ohio.
Morgenthaler Ventures Headquarter Location
2710 Sand Hill Road 100
Menlo Park, California, 94025,
United States
(650) 388-7600
Expert Collections containing Morgenthaler Ventures
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Morgenthaler Ventures in 1 Expert Collection, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
113 items
Latest Morgenthaler Ventures News
Feb 11, 2019
Nuvaira , a Minneapolis, Minn.-based developer of novel therapeutic medical devices to treat obstructive lung diseases, closed a $79m equity financing. The round was led by U.S. Venture Partners, with participation from Endeavour Vision, Qiming Venture Partners, Lightstone Ventures and Richard King Mellon Foundation and existing investors Advanced Technology Ventures, Morgenthaler Ventures, Split Rock Partners, Versant Ventures, Vertex Venture Holdings, and Windham Venture Partners. The company intends to use the funds to support the pivotal AIRFLOW-3 clinical trial for FDA approval and to implement a targeted clinical development strategy in key European markets. Led by Dennis Wahr, M.D., Chief Executive Officer, Nuvaira provides the lung denervation system that addresses airway hyper-responsiveness, a pathophysiologic underpinning of both COPD and asthma in a procedure called Targeted Lung Denervation (TLD). Its proprietary technology has demonstrated safety and feasibility in three clinical studies: IPS-I/II, AIRFLOW-1, and, most recently, the AIRFLOW-2 sham controlled randomized clinical trial, which was presented at the European Respiratory Society conference in September 2018. The Nuvaira Lung Denervation System is CE Mark approved, and is under clinical investigation and is not commercially available in the USA. Nuvaira and dNerva are registered trademarks of Nuvaira, Inc. The company also announced that Lisa Rogan has joined its executive team as senior vice president of market development, bringing with her over 20 years of medical device industry expertise in commercializing disruptive diagnostic and therapeutic technologies, including ten years of experience with interventional pulmonary devices targeting treatment of severe COPD. FinSMEs 11/02/2019
Morgenthaler Ventures Investments
499 Investments
Morgenthaler Ventures has made 499 investments. Their latest investment was in Relievant Medsystems as part of their Series G on October 10, 2020.
Morgenthaler Ventures Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
10/29/2020 | Series G | Relievant Medsystems | $70M | No | 7 | |
2/14/2019 | Series E | Nuvaira | $79M | No | 4 | |
12/28/2018 | Series F | NuoDB | $30.55M | No | 1 | |
10/11/2018 | Series D - II | |||||
11/1/2017 | Series E - II |
Date | 10/29/2020 | 2/14/2019 | 12/28/2018 | 10/11/2018 | 11/1/2017 |
---|---|---|---|---|---|
Round | Series G | Series E | Series F | Series D - II | Series E - II |
Company | Relievant Medsystems | Nuvaira | NuoDB | ||
Amount | $70M | $79M | $30.55M | ||
New? | No | No | No | ||
Co-Investors | |||||
Sources | 7 | 4 | 1 |
Morgenthaler Ventures Portfolio Exits
97 Portfolio Exits
Morgenthaler Ventures has 97 portfolio exits. Their latest portfolio exit was Doximity on June 24, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
6/24/2021 | IPO | Public | 6 | ||
11/25/2020 | Acquired | 7 | |||
1/22/2020 | Acquired | 1 | |||
Date | 6/24/2021 | 11/25/2020 | 1/22/2020 | ||
---|---|---|---|---|---|
Exit | IPO | Acquired | Acquired | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 6 | 7 | 1 |
Morgenthaler Ventures Acquisitions
12 Acquisitions
Morgenthaler Ventures acquired 12 companies. Their latest acquisition was Arisdyne Systems on June 18, 2008.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
6/18/2008 | Debt | $10.85M | Acquired | |||
7/9/2007 | Acquired | |||||
9/19/2006 | Debt | $7.5M | Acquired | |||
7/15/2006 | Series D | |||||
5/19/2006 |
Date | 6/18/2008 | 7/9/2007 | 9/19/2006 | 7/15/2006 | 5/19/2006 |
---|---|---|---|---|---|
Investment Stage | Debt | Debt | Series D | ||
Companies | |||||
Valuation | |||||
Total Funding | $10.85M | $7.5M | |||
Note | Acquired | Acquired | Acquired | ||
Sources |
Morgenthaler Ventures Team
10 Team Members
Morgenthaler Ventures has 10 team members, including current Founding Partner, David Morgenthaler.
Name | Work History | Title | Status |
---|---|---|---|
David Morgenthaler | Founding Partner | Current | |
David Morgenthaler | Founding Partner | Current | |
Robert C. Bellas | General Partner | Current | |
Jason Lettmann | Promedior, Split Rock Partners, Accenture, and University of Iowa | General Partner | Current |
Rebecca Lynn | NextCard, and Procter & Gamble | General Partner | Current |
Name | David Morgenthaler | David Morgenthaler | Robert C. Bellas | Jason Lettmann | Rebecca Lynn |
---|---|---|---|---|---|
Work History | Promedior, Split Rock Partners, Accenture, and University of Iowa | NextCard, and Procter & Gamble | |||
Title | Founding Partner | Founding Partner | General Partner | General Partner | General Partner |
Status | Current | Current | Current | Current | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.